FDA calls for withdrawal of weight loss drug Belviq after trials find cancer link [CNN]
EISAI CO S/ADR (ESALY)
NASDAQ:AMEX Investor Relations:
eisai.com/ir/index.html
Company Research
Source: CNN
(CNN) incidence of cancer among users Eisai Co., the maker of Belviq, has agreed to withdraw the drug, the FDA said. The FDA announced last month it was reviewing trial results on the prescription drug, also known as lorcaserin, an oral medication for obese adults, because of potential cancer risks. The agency Thursday asked people to stop taking the drug. The "potential risk of cancer associated with the drug outweighs the benefit of treatment," Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a statement. Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says The agency said in a separate news release that clinical trials showed lorcaserin increased the risk of a number of cancers, including pancreatic, colorectal and lung. Read "As noted in a new Drug Safety Communication issued today, patients should stop using the medication Belviq and Belviq XR (lorcaserin) and talk to their health care professionals about other treat
Show less
Read more
Impact Snapshot
Event Time:
ESALY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ESALY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ESALY alerts
High impacting EISAI CO S/ADR news events
Weekly update
A roundup of the hottest topics